Clément VUARCHEY

En résumé

Entreprises

• Biotechspin - Director

  2012 - maintenant Biowebspin is the #1 academia-industry partnering network in Life Sciences.
  For academics, Biowebspin is the platform to find industrial partners and funding for their research projects matching R&D programs of more than 500 leading Life Sciences companies and foundations.
  For industrials, Biowebspin is the platform to detect new research projects and collaboration opportunities among 2 million researchers worldwide in 30,000 organizations.
  Biowebspin is also the first source of information and expert interviews about academia-industry partnering, technology transfer and licensing in Life Sciences.
  

• Spinotech - Director

  2012 - 2013 Spinotech provides business solutions for the biotech, pharma, and medtech sectors. Our mission is to solve your business development and online visibility problems, while catering to your company’s precise needs. Spinotech’s strategy is innovative by our solutions created for the life science industry, delivering easy-to-access tools for the non-technical professional. These automated tools, like our e-marketing platform or business development application, drive the improvement of online visibility, influence, and Web traffic.
  
  Spinotech operates on the largest biotech, pharma, and medtech database with over 80,000 companies and institutions. Maintaining the most comprehensive coverage of life science professionals, we have 4 million bioscience professionals within contact reach.
  
  Our customers choose Spinotech for our commitment to the success of their venture and the satisfaction delivered from our consulting expertise.
  

• Fluofarma - Global R&D project manager junior

  Bordeaux 2011 - 2011 Drug Discovery,
  Fluofarma is a CRO specialised in developping Cell Based assay, based on flow cytometry, confocal microscopy (HCS) and laser scanning cytometry in neurology, oncology & inflammation and toxicology.
  
  I developed a Strategic global R&D project tool which permits to decide which R&D projects Fluofarma should pursue depending on the market, the technology trends and Fluofarma actual knowhow. This tool is based on the lineage management approach discovered by the Center of Management Science of Mines Paris Tech and is specially redesigned for the purpose of biotechnology strategies. It mixes tools for innovation and conception, market analysis, technology scouting, portofolio management, and business intelligence. Thanks to this strategic approach, Fluofarma can decide and manage its intern R&D projects efficiently and with less cost.

• Genopole - Business Developper Consultant junior

  Evry 2010 - 2011 Realization of the business plan of a future start-up specialized in the prevention of genetic diseases

• Laboratory of Liposomes, University of Zurich. - Research Internship

  2010 - 2010 Drug Delivery,
  
  Projects (financed by Novartis):
  - New strategies to target macrophages
  - New immunotherapies against TAMS: Use of Zoledronate or Statins liposomes
  
  Methods: Design, formulation, optimisation and bioconjugaison of liposomes with different encapsulated drugs, Biological evaluation in vitro and in vivo, FACS, and ELISA
  
  Albumin coated liposomes: a novel platform for macrophage specific drug delivery. Vuarchey C, Kumar S, Schwendener R.Nanotechnology Development 1:e2, 2011. PMID

• BioMérieux - Engineering Internship

  MARCY-L'ETOILE 2009 - 2009 Projects:
  - Purification of Antibodies (protein A, gel...)
  - Opposition to a Patent on a method to detect 25 OH vitamin D
  - Study of new bioconjugaison to improve the sensibility of ELISA

• Rotarex - Engineering Internship

  2006 - 2006 Engineering assistant in mechanics in the R&D department in Shanghai

Formations

• Université Paris Dauphine - Mines Paris Tech -INSTN (Paris)

  Paris 2011 - 2011 Master
  
  Management of Technology and Innovation - Partner Schools: Polytechnique Paris & HEC Paris,
  Awards: Top Honors

• Université Lyon I - Claude Bernard

  Villeurbanne 2010 - 2011 Master of Research (double degree)
  
  Cell and Molecular Biology

• University Of Birmingham (Edgbaston Birmingham)

  Edgbaston Birmingham 2009 - 2010 Erasmus
  
  Genetic Engineering, Molecular Biology, Pharmacology

• Institut National Des Sciences Appliquées De Lyon SGM

  Lyon 2005 - 2011 Master
  
  Biotechnology - 2007-2010: Speciality : Biochemistry and Biotechnology Engineering (With Honors)
  2005-2007: ASINSA Program-international program with Asian Students (rank : 20 / 581)
  Basic Engineering courses : maths, chemistry, physics, thermodynamics…
  
  Activities and Societies: President of the Association of the Biochemists of INSA of Lyon (ABIL), responsible of the partnership with Biomerieux

Réseau

• Alain BOUVET

• Alexandre MARCHAIS

• Caroline RANQUET

• Clara PAVY - BRAC DE LA PERRIERE

• Elsa KANCEL

• Guillaume BRION

• Marc CARRÉ

• Reine MALEK

• Virginie RACANO